CareDx (CDNA)

• Market cap: $2.43B
• 1 day: -0.7%
• 5 days: 1.96%
• 1 month: 63.07%
• 3 months: 119.16%
• 6 months: 145.55%
• Year to date: 145.04%
• 1 year: 276.4%
• 5 years: -35.43%
• 10 years: 883.23%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Employees: 765